Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
7
self-reported band not used
Founded
2016
10 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Description
Capitalising on Peter Mac's unique expertise in all pathology disciplines to deliver oncology laboratory assays including novel tests and technologies, nexomics was established in 2016 to support clinical trials and medical testing.
Our dedicated state-of-the-art laboratories are located at the Victorian Comprehensive Cancer Centre, one of the world’s leading cancer research, education and treatment centres globally and Australia’s only public hospital solely dedicated to caring for people affected by cancer. In the past 10 years our team has delivered 1000+ clinical studies from Phases I to IV in all major oncology indications.
Our unique lab-to-bedside genomics model supports the implementation of novel tests and technologies.
Nexomics’s extensive capabilities, combined with our clinical and scientific expertise ensure we can serve as a key partner in cancer research programs.
Our team is comprised of medical, scientific and commercialisation experts in all pathology disciplines. We are driven to transform cancer diagnostics, leading in scientific discoveries and delivering cutting edge services.
Clinical Testing: Nexomics is an expert contract service provider offering oncology laboratory assays to support clinical trials and medical testing.
Molecular Cancer Genomics: Nexomics offers state-of-the-art molecular services on multiple high-throughput test platforms that can interrogate RNA, DNA, ctDNA and protein from a large number of samples simultaneously.We provide clinicians with a personalised and user friendly reporting that outlines the genomic findings and patient treatment options.
In the past 10 years our team has delivered 1000+ clinical studies from Phases I to IV in all major oncology indications.
Specialties
All 5 specialties
- Clinical Trials
- Genomic Testing
- Molecular Testing
- Anatomical Pathology
- Immunology
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|
All codes: AU
Addresses
- AU305 Grattan St; Melbourne, 3000
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
How many people work at Nexomics at Peter MacCallum Cancer Centre?
7 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does Nexomics at Peter MacCallum Cancer Centre have offices?
One address on record, Australia only.
Has Nexomics at Peter MacCallum Cancer Centre raised funding?
None linked to this brand.
What does Nexomics at Peter MacCallum Cancer Centre list as its specialties?
Five tags on the brand's own list, among them immunology and clinical trials.
Which companies are listed alongside Nexomics at Peter MacCallum Cancer Centre?
2 profiles list Nexomics at Peter MacCallum Cancer Centre as a peer — 62nd percentile in Hospitals and Health Care. It lists ten peers of its own.